Bloomberg Law
Feb. 21, 2018, 3:27 PM UTC

Is California Turning Stem Cells Into Dollars or Debts?

Joyce Cutler

California received its first royalty check on $3 billion in bonds sold to support stem cell research.

Now, debate is kicking up on whether a $190,346 check is enough of a return on investment to get voters’ OK for billions more to fund the state stem cell agency, the California Institute for Regenerative Medicine (CIRM).

The payment from City of Hope, a Los Angeles County-based research center, comes as supporters of CIRM gear up for a 2020 voter initiative to fund another series of billion-dollar bond sales. The current authority to sell bonds ends in 2019.

Connecticut, Maryland, ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.